Alternative fusion protein strategies to express recalcitrant QconCAT proteins for quantitative proteomics of human drug metabolizing enzymes and transporters.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Proteome Research

• Publication date

  2013-10-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/pr400279uPMID 24124648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption.

  2013cited by this paper
• Prediction of Missed Proteolytic Cleavages for the Selection of Surrogate Peptides for Quantitative Proteomics

  2012cited by this paper
• Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?

  2012cited by this paper
• QconCATs: design and expression of concatenated protein standards for multiplexed protein quantification

  2012cited by this paper
• CONSeQuence: Prediction of Reference Peptides for Absolute Quantitative Proteomics Using Consensus Machine Learning Approaches*

  2011cited by this paper
• Investigation of solubilization and digestion methods for microsomal membrane proteome analysis using data‐independent LC‐MSE

  2011cited by this paper
• Quantitative protein determination for CYP induction via LC‐MS/MS

  2011cited by this paper
• Absolute Quantification of the Glycolytic Pathway in Yeast:

  2011cited by this paper
• Concepts and tools to exploit the potential of bacterial inclusion bodies in protein science and biotechnology

  2011cited by this paper
• Global absolute quantification of a proteome: Challenges in the deployment of a QconCAT strategy

  2011cited by this paper
• Protein-surfactant interactions: a tale of many states.

  2011cited by this paper
• A general approach to anionic acid-labile surfactants with tunable properties.

  2010cited by this paper
• Efflux and uptake transporters as determinants of statin response

  2010cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry.

  2010cited by this paper
• A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin.

  2010cited by this paper
• Multiple-approaches to the identification and quantification of cytochromes P450 in human liver tissue by mass spectrometry.

  2009cited by this paper
• Mass Spectrometry-Based Label-Free Quantitative Proteomics

  2009cited by this paper
• Isotope dilution strategies for absolute quantitative proteomics.

  2009cited by this paper
• Predicting free energy changes using structural ensembles

  2009cited by this paper
• A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recognition of covariates.

  2009cited by this paper
• Absolute quantification of human uridine-diphosphate glucuronosyl transferase (UGT) enzyme isoforms 1A1 and 1A6 by tandem LC-MS.

  2008cited by this paper
• A gel‐free MS‐based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes

  2008cited by this paper
• Comparative Evaluation of Current Peptide Production Platforms Used in Absolute Quantification in Proteomics*S

  2008cited by this paper
• Protein Standard Absolute Quantification (PSAQ) for improved investigation of staphylococcal food poisoning outbreaks

  2008cited by this paper
• QCAL—a novel standard for assessing instrument conditions for proteome analysis

  2008cited by this paper
• Absolute Multiplexed Quantitative Analysis of Protein Expression during Muscle Development Using QconCAT*

  2007cited by this paper
• Enhancement of soluble protein expression through the use of fusion tags.

  2006cited by this paper
• Protein quality in bacterial inclusion bodies.

  2006cited by this paper
• Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes

  2006cited by this paper
• Native folding of aggregation-prone recombinant proteins in Escherichia coli by osmolytes, plasmid- or benzyl alcohol–overexpressed molecular chaperones

  2005cited by this paper
• Metabolic Labeling of Proteins for Proteomics*

  2005cited by this paper
• Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides

  2005cited by this paper
• Advanced genetic strategies for recombinant protein expression in Escherichia coli.

  2005cited by this paper
• Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes.

  2004cited by this paper
• Plasma Membrane Localization of Multidrug Resistance-Associated Protein Homologs in Brain Capillary Endothelial Cells

  2004cited by this paper
• Predicting P-Glycoprotein Effects on Oral Absorption: Correlation of Transport in Caco-2 with Drug Pharmacokinetics in Wild-Type and mdr1a(-/-) Mice in Vivo

  2004cited by this paper
• Protein aggregation in recombinant bacteria: biological role of inclusion bodies

  2003cited by this paper
• Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS

  2003cited by this paper
• Protein aggregated into bacterial inclusion bodies does not result in protection from proteolytic digestion

  2002cited by this paper
• Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.

  2001cited by this paper
• Engineering proteins to facilitate bioprocessing.

  1994cited by this paper
• Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments

  year unknowncited by this paper

• Overlooked aspects of scaling enzyme activity through abundance across tissues and individuals: Insights from kcat measurements in matched liver and intestinal samples

  2025cites this paper
• Transporter Expressions as Part of Required Scaling Factor to Support In vitro In vivo Extrapolation for Blood-Brain Barrier Drug Permeability.

  2025cites this paper
• Absolute Membrane Protein Abundance of P-gp, BCRP and MRPs in Term Human Placenta Tissue and Commonly Used Cell Systems: Application in PBPK Modeling of Placental Drug Disposition.

  2024cites this paper
• Research Progress in Isotope Labeling/Tags-Based Protein Quantification and Metrology Technologies.

  2024cites this paper
• Sex- and Lifestyle-Related Factors are Associated with Altered Hepatic CYP Protein Levels in People Diagnosed with Mental Disorders

  2023influential citation
• Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS/MS proteomics using a QconCAT technique.

  2023cites this paper
• Toward Systems-Informed Models for Biologics Disposition: Covariates of the Abundance of the Neonatal Fc Receptor (FcRn) in Human Tissues and Implications for Pharmacokinetic Modelling.

  2023influential citation
• A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteins.

  2022cites this paper
• Proteomic quantification of perturbation to pharmacokinetic target proteins in liver disease.

  2022cites this paper
• Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis

  2022cites this paper
• Identification of regulatory variants of carboxylesterase 1 (CES1): A proof‐of‐concept study for the application of the Allele‐Specific Protein Expression (ASPE) assay in identifying cis‐acting regulatory genetic polymorphisms

  2022cites this paper
• Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment

  2021cites this paper
• Proteomic Quantification of Changes in Abundance of Drug-Metabolizing Enzymes and Drug Transporters in Human Liver Cirrhosis: Different Methods, Similar Outcomes

  2021cites this paper
• Mass spectrometry-based targeted proteomics method for the quantification of clinically relevant drug metabolizing enzymes in human specimens.

  2021cites this paper
• Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects

  2021cites this paper
• Mass spectrometry‐based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin

  2020cites this paper
• Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine

  2020cites this paper
• Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters

  2020cites this paper
• Characterization of CYP2B6 K262R allelic variants by quantitative allele-specific proteomics using a QconCAT standard.

  2020cites this paper
• Targeted proteomics-based quantitative protein atlas of pannexin and connexin subtypes in mouse and human tissues and cancer cell lines.

  2020cites this paper
• Quantification of Proteins Involved in Intestinal Epithelial Handling of Xenobiotics

  2020cites this paper
• Mass Spectrometry of Human Transporters.

  2020cites this paper
• Response to the Comments on "Determining Allele-Specific Protein Expression (ASPE) Using a Novel Quantitative Concatamer Proteomics Method".

  2019cites this paper
• Toward a Consensus on Applying Quantitative Liquid Chromatography‐Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper

  2019cites this paper
• Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practice.

  2019influential citation
• Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients.

  2019cites this paper
• Développement et validation de méthodes de protéomique innovantes pour des applications de biochimie clinique

  2019cites this paper
• Identification and quantification of blood–brain barrier transporters in isolated rat brain microvessels

  2018cites this paper
• GASP and FASP are Complementary for LC–MS/MS Proteomic Analysis of Drug‐Metabolizing Enzymes and Transporters in Pig Liver

  2018cites this paper
• Response to "Determining Allele-Specific Protein Expression (ASPE) Using a Novel Quantitative Concatamer Based Proteomics Method".

  2018cites this paper
• Dose adjustment in orphan disease populations: the quest to fulfill the requirements of physiologically based pharmacokinetics

  2018cites this paper
• PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol

  2018cites this paper
• Data Generated by Quantitative Liquid Chromatography-Mass Spectrometry Proteomics Are Only the Start and Not the Endpoint: Optimization of Quantitative Concatemer-Based Measurement of Hepatic Uridine-5′-Diphosphate–Glucuronosyltransferase Enzymes with Reference to Catalytic Activity

  2018cites this paper
• Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic Activity

  2017influential citation
• Correlation of pre‐operative plasma protein concentrations in cardiac surgery patients with bleeding outcomes using a targeted quantitative proteomics approach

  2017cites this paper
• Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing Enzymes

  2017cites this paper
• A strategy for absolute proteome quantification with mass spectrometry by hierarchical use of peptide‐concatenated standards

  2016cites this paper
• Design and expression of a QconCAT protein to validate Hi3 protein quantification of influenza vaccine antigens.

  2016cites this paper
• Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics

  2016cites this paper
• Physiological scaling factors and mechanistic models for prediction of renal clearance from in vitro data

  2016cites this paper
• Breast Cancer Resistance Protein Abundance, but Not mRNA Expression, Correlates With Estrone-3-Sulfate Transport in Caco-2.

  2016cites this paper
• A proteomic study on liver impairment in rat pups induced by maternal microcystin-LR exposure.

  2016cites this paper
• In Vitro–In Vivo Extrapolation Scaling Factors for Intestinal P-Glycoprotein and Breast Cancer Resistance Protein: Part I: A Cross-Laboratory Comparison of Transporter-Protein Abundances and Relative Expression Factors in Human Intestine and Caco-2 Cells

  2016influential citation
• Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro–in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques

  2015cites this paper
• The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug development

  2015cites this paper
• Ethnic Variability in the Expression of Hepatic Drug Transporters: Absolute Quantification by an Optimized Targeted Quantitative Proteomic Approach

  2015cites this paper
• Choice of LC-MS Methods for the Absolute Quantification of Drug-Metabolizing Enzymes and Transporters in Human Tissue: a Comparative Cost Analysis

  2015cites this paper
• Application of an LC-MS/MS method for the simultaneous quantification of human intestinal transporter proteins absolute abundance using a QconCAT technique.

  2015cites this paper
• Towards a fully mechanistic prediction of oral drug absorption: Investigating intestinal transporter abundance and function relationships

  2015cites this paper
• Ten years of QconCATs: Application of multiplexed quantification to small medically relevant proteomes

  2015cites this paper
• Plasma QconCATs reveal a gender-specific proteomic signature in apheresis platelet plasma supernatants.

  2015cites this paper
• Application of cutting-edge proteomics technologies for elucidating host-bacteria interactions.

  2014cites this paper
• Protein expression of various hepatic uridine 5′‐diphosphate glucuronosyltransferase (UGT) enzymes and their inter‐correlations: a meta‐analysis

  2014cites this paper
• Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.

  2014cites this paper
• Simultaneous Quantification of the Abundance of Several Cytochrome P450 and Uridine 5′-Diphospho-Glucuronosyltransferase Enzymes in Human Liver Microsomes Using Multiplexed Targeted Proteomics

  2014cites this paper
• Optimized Approaches for Quantification of Drug Transporters in Tissues and Cells by MRM Proteomics

  2014cites this paper
• Quantitative Targeted Proteomics for Membrane Transporter Proteins: Method and Application

  2014cites this paper
• How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion

  2014cites this paper
• Quantification of the proteins of the bacterial ribosome using QconCAT technology.

  2014cites this paper
• Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis and Transporters in Patients With Colorectal Cancer Metastasis

  year unknowncites this paper